Equity Research, Broker Reports, and media content on Redx Pharma Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Redx Pharma Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Redx Pharma Plc

Company Profile

  • Personnel:
  • James Mead, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Redx Pharma Plc. We currently have 133 research reports from 7 professional analysts.

  • Open: 68.0p
  • Range Today: 67.0/69.0p
  • 52 Week: 52.0/130p
  • Daily Volume: 6.2k
  • Daily Liquidity: 0.00%
  • # Shares: 333.4m
  • Market Cap: £226.7m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
27Jun22 07:00 RNS Redx Pharma plc - Encouraging Data on Porcupine and ROCK Inhibitors
23Jun22 07:00 RNS Redx Pharma plc - Interim Results for the Six Months Ended 31 March
20Jun22 07:00 RNS Redx Pharma plc - Redx to Present at the ECM Congress
16Jun22 07:00 RNS Redx Pharma plc - Notice of Interim Results
15Jun22 07:00 RNS Redx Pharma plc - Pan-RAF Inhibitor to Enter Clinical Development
09Jun22 16:34 RNS Redx Pharma plc - TR-1: Notification of major holdings
08Jun22 13:28 RNS Redx Pharma plc - TR-1: Notification of major holdings
  • Frequency of research reports

     

  • Research reports on

    Redx Pharma Plc

  • Providers covering

    Redx Pharma Plc